About Genome & Company
Genome & Company is a company based in Seongnam-si (South Korea) founded in 2015 by Jisoo Pae.. The company has 102 employees as of December 31, 2024. Genome & Company has completed 1 acquisition, including List Biological Laboratories. Genome & Company operates in a competitive market with competitors including Moderna, BeiGene, Incyte, Novozymes and Ultragenyx, among others.
- Headquarter Seongnam-si, South Korea
- Employees 102 as on 31 Dec, 2024
- Founders Jisoo Pae
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Genome & Co.
-
Annual Revenue
$18.81 M (USD)94.07as on Dec 31, 2024
-
Net Profit
$-13.64 M (USD)57.63as on Dec 31, 2024
-
EBITDA
$-12.02 M (USD)63.04as on Dec 31, 2024
-
Latest Funding Round
$2.96 M (USD), Post-IPO
Apr 28, 2020
-
Investors
DongKoo Bio& Pharma
& 1 more
-
Employee Count
102
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Genome & Company
Genome & Company is a publicly listed company on the KRX with ticker symbol 314130 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Genome & Company
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $3.0M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Post-IPO - Genome & Company | Valuation |
investors |
|
| Jun, 2016 | Amount | Seed - Genome & Company | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genome & Company
Genome & Company has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include DongKoo Bio& Pharma and DSC Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital is invested primarily in South Korean startups.
|
Founded Year | Domain | Location | |
|
Company focused on generic medicines, OTC, stem cell extraction kits, medical apparatus, cosmetics & CMO services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genome & Company
Genome & Company has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include List Biological Laboratories. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Specializes in the production of research reagents
|
1978 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Genome Company
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genome & Company Comparisons
Competitors of Genome & Company
Genome & Company operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, Novozymes and Ultragenyx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genome & Company
Frequently Asked Questions about Genome & Company
When was Genome & Company founded?
Genome & Company was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Genome & Company located?
Genome & Company is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Who is the current CEO of Genome & Company?
Jisoo Pae is the current CEO of Genome & Company. They have also founded this company.
How many employees does Genome & Company have?
As of Dec 31, 2024, the latest employee count at Genome & Company is 102.
What is the annual revenue of Genome & Company?
Annual revenue of Genome & Company is $18.81M as on Dec 31, 2024.
What does Genome & Company do?
The company was founded in 2015 in Seongnam-si, South Korea, and operates in the biotechnology sector focused on microbiome therapeutics. Innovative drug candidates are developed through the GNOCLE platform, targeting immuno-oncology and other conditions. The pipeline includes GEN-001 and GEN-004 for cancer treatments, as well as SB-121 for autism and obstetric diseases. Leadership is provided by Co-Founder and CEO Jisoo Pae.
Who are the top competitors of Genome & Company?
Is Genome & Company publicly traded?
Yes, Genome & Company is publicly traded on KRX under the ticker symbol 314130.
How many acquisitions has Genome & Company made?
Genome & Company has made 1 acquisition, including List Biological Laboratories.
Who are Genome & Company's investors?
Genome & Company has 2 investors. Key investors include DongKoo Bio& Pharma, and DSC Investment.
What is Genome & Company's ticker symbol?
The ticker symbol of Genome & Company is 314130 on KRX.